Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies (Q47232994)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2004
edit
Language Label Description Also known as
English
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies
scientific article published in July 2004

    Statements

    Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit